Company profile: Mikart
1.1 - Company Overview
Company description
- Provider of integrated CDMO services, technology and support for the development, manufacturing and packaging of solid dose and non-sterile liquid pharmaceuticals.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Mikart
AnaBios
HQ: United States
Website
- Description: Provider of human-focused contract research services and products for biotech and pharma drug discovery, using ex vivo studies of human donor organs and tissues. Includes ethical human tissue and cell procurement, human primary cells and media, RIN analysis, custom tissue collection, cryopreserved human hepatocytes, and high-quality human heart tissue for cardiovascular preclinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AnaBios company profile →
AustinPx
HQ: United States
Website
- Description: Provider of formulation and processing technologies for drug manufacturing, offering KinetiSol Technology for amorphous solid dispersions, bioavailability enhancement via amorphous dispersions, particle size reduction and lipid delivery, dosage form development, rapid screening, phase-appropriate analytics, and oral drug product manufacturing for preclinical through Phase II.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AustinPx company profile →
Abveris
HQ: United States
Website
- Description: Provider of antibody discovery solutions for reagent and therapeutic applications, offering DiversimAb hyperimmune mouse technology for diverse monoclonal antibodies; Beacon single B-cell screening; hybridoma discovery (production, purification, sequencing, recombinant production); antigen production and design; anti-idiotype antibody discovery; and fully human antibodies via humanized mice.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abveris company profile →
AGC Biologics
HQ: Denmark
Website
- Description: Provider of biopharmaceutical contract development and manufacturing services, including microbial fermentation and mammalian cell culture cGMP manufacturing, process development and scale-up, and production of biopharmaceuticals for pre-clinical, clinical, and market supply. Offers CDMO services for biologics and ATMPs, AGCellerate (DNA-to-IND), lentiviral and AAV vector production, and ADC development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AGC Biologics company profile →
Modality Solutions
HQ: United States
Website
- Description: Provider of package engineering and controlled-environment logistics solutions for highly regulated industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Modality Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Mikart
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Mikart
2.2 - Growth funds investing in similar companies to Mikart
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Mikart
4.2 - Public trading comparable groups for Mikart
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →